Arxes1 inhibitors are a class of chemical compounds that specifically target and modulate the activity of the Arxes1 protein, a lesser-known but functionally significant protein involved in various cellular processes. Although the precise biological functions of Arxes1 are still being elucidated, it is believed to play a role in cellular signaling pathways, protein-protein interactions, and potentially in the regulation of gene expression. Inhibitors of Arxes1 are designed to interfere with its normal functions by binding to specific regions of the protein, such as its active sites or domains critical for its interaction with other cellular molecules. By blocking these interactions, Arxes1 inhibitors can disrupt the protein's role within the cell, providing a means to study its function and the pathways it influences.
The development of Arxes1 inhibitors involves a detailed investigation into the structure and functional domains of the Arxes1 protein. Techniques such as X-ray crystallography, cryo-electron microscopy, and nuclear magnetic resonance (NMR) spectroscopy are employed to map the three-dimensional structure of Arxes1, revealing key areas where inhibitors can bind. Computational modeling and molecular docking studies are then used to design inhibitors that can effectively target these regions, optimizing their fit and binding affinity. High-throughput screening of chemical libraries may also be utilized to identify potential lead compounds that exhibit inhibitory activity against Arxes1. Once these candidate inhibitors are identified, they undergo rigorous testing and optimization to enhance their specificity, potency, and stability. Biochemical assays are conducted to measure the inhibitors' effects on Arxes1 activity, and additional studies are performed to understand their impact on cellular processes. Through this comprehensive approach, Arxes1 inhibitors are developed as important tools for probing the molecular functions of Arxes1, shedding light on its role in cellular regulation, and contributing to the broader understanding of protein interactions and signaling pathways in cells.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent, non-selective inhibitor of protein kinases, which may alter signaling pathways that Arxes1 is part of or interacts with. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, potentially affecting pathways involved in cell survival and proliferation, which Arxes1 might be a part of. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, potentially affecting the MAPK/ERK signaling pathway that Arxes1 could be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, which may affect cellular growth and autophagy pathways possibly linked to Arxes1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, potentially affecting proteins in the MAPK/ERK pathway, which could include Arxes1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially influencing stress response pathways that Arxes1 may be part of. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, potentially affecting pathways related to apoptosis that could involve Arxes1. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor, potentially altering pathways in which Arxes1 is involved. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, potentially affecting gene expression in pathways that include Arxes1. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
A multi-kinase inhibitor, potentially affecting a range of signaling pathways that could include Arxes1. | ||||||